chr4-2831573-G-A

Variant summary

Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM1PM2PM5PP3PP5_Very_Strong

The NM_001122681.2(SH3BP2):​c.1244G>A​(p.Arg415Gln) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000014 in 1,427,572 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R415L) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

SH3BP2
NM_001122681.2 missense, splice_region

Scores

8
7
3

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 7.78

Publications

19 publications found
Variant links:
Genes affected
SH3BP2 (HGNC:10825): (SH3 domain binding protein 2) The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases , and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
SH3BP2 Gene-Disease associations (from GenCC):
  • cherubism
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 15 ACMG points.

PM1
In a hotspot region, there are 9 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 6 uncertain in NM_001122681.2
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr4-2831573-G-C is described in ClinVar as Pathogenic. ClinVar VariationId is 7550.Status of the report is criteria_provided_single_submitter, 1 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.821
PP5
Variant 4-2831573-G-A is Pathogenic according to our data. Variant chr4-2831573-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 7551.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SH3BP2NM_001122681.2 linkc.1244G>A p.Arg415Gln missense_variant, splice_region_variant Exon 9 of 13 ENST00000503393.8 NP_001116153.1 P78314-1A0A384N6E5
SH3BP2NM_001145856.2 linkc.1415G>A p.Arg472Gln missense_variant, splice_region_variant Exon 9 of 13 NP_001139328.1 P78314-4
SH3BP2NM_001145855.2 linkc.1328G>A p.Arg443Gln missense_variant, splice_region_variant Exon 9 of 13 NP_001139327.1 P78314-3
SH3BP2NM_003023.4 linkc.1244G>A p.Arg415Gln missense_variant, splice_region_variant Exon 9 of 13 NP_003014.3 P78314-1A0A384N6E5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SH3BP2ENST00000503393.8 linkc.1244G>A p.Arg415Gln missense_variant, splice_region_variant Exon 9 of 13 1 NM_001122681.2 ENSP00000422168.3 P78314-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000140
AC:
2
AN:
1427572
Hom.:
0
Cov.:
32
AF XY:
0.00000283
AC XY:
2
AN XY:
707110
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32572
American (AMR)
AF:
0.00
AC:
0
AN:
40568
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25546
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37690
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81914
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50554
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5722
European-Non Finnish (NFE)
AF:
0.00000183
AC:
2
AN:
1093974
Other (OTH)
AF:
0.00
AC:
0
AN:
59032
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.000945
Hom.:
0

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fibrous dysplasia of jaw Pathogenic:3
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 415 of the SH3BP2 protein (p.Arg415Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with cherubism (PMID: 11381256, 21045962, 22795151, 24382142, 24608212, 26064398, 28644570, 30236129). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 7551). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SH3BP2 function (PMID: 16786512, 22153077). For these reasons, this variant has been classified as Pathogenic. -

Jun 01, 2001
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Jun 07, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Pathogenic:1
Dec 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SH3BP2: PM1:Strong, PM2, PM5, PS4:Moderate -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.56
BayesDel_addAF
Pathogenic
0.44
D
BayesDel_noAF
Pathogenic
0.40
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.52
D;.;D;D;.;D
Eigen
Uncertain
0.54
Eigen_PC
Uncertain
0.52
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.91
.;D;.;.;D;D
M_CAP
Pathogenic
0.34
D
MetaRNN
Pathogenic
0.82
D;D;D;D;D;D
MetaSVM
Pathogenic
1.0
D
PhyloP100
7.8
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.9
N;N;N;N;N;N
REVEL
Pathogenic
0.75
Sift
Uncertain
0.013
D;D;D;D;D;D
Sift4G
Benign
0.27
T;T;T;T;T;T
Polyphen
0.99
D;.;D;D;.;D
Vest4
0.59
MVP
0.96
MPC
0.46
ClinPred
0.95
D
GERP RS
5.7
Varity_R
0.89
Mutation Taster
=3/97
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121909149; hg19: chr4-2833300; API